Talis Biomedical Corporation (TLIS) Financials

TLIS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 107.2 million 25.7 million
2023-06-30 123.1 million 26.9 million
2023-03-31 133.1 million 22.9 million
2022-12-31 169.3 million 42.6 million

TLIS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -11.2 million 1.1 million
2023-06-30 -14.8 million 1.1 million
2023-03-31 -16.5 million 1.2 million
2022-12-31 -13.6 million 1.3 million

TLIS Net Income

No data available :(

TLIS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 88.0 million - 20.1 million
2023-06-30 98.2 million - 20.4 million
2023-03-31 113.0 million - 14.7 million
2022-12-31 130.2 million - 33.6 million

TLIS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.8 million
2023-06-30 1.8 million
2023-03-31 1.8 million
2022-12-31 1.8 million

TLIS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 70000 8.3 million 8.8 million -
2023-06-30 485000 10.6 million 6.4 million -
2023-03-31 24000 13.8 million 6.4 million -
2022-12-31 49000 15.2 million 10.8 million -

TLIS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 76000 6000
2023-06-30 48000 7000
2023-03-31 137000 20000
2022-12-31 107000 2.3 million

TLIS

Price: $9.16

52 week price:
4.35
9.32

Earnings Per Share: -34.12 USD

P/E Ratio: -0.20

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 73600

Market Capitalization: 15.4 million

Links: